Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses
Launched by JOHNSON & JOHNSON SURGICAL VISION, INC. · Aug 26, 2021
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimum 22 years of age
- • Bilateral cataracts for which posterior chamber IOL implantation has been planned
- • Preoperative best corrected distance visual acuity (BCDVA) of 20/40 Snellen or worse with or without a glare source
- • Potential for postoperative best corrected visual acuity of 20/30 Snellen or better
- * Corneal astigmatism parameters:
- • Normal corneal topography and no irregular corneal astigmatism
- • Postoperative astigmatism can be surgically managed to be less than 1 D in each eye
- • Clear intraocular media other than cataract in each eye
- • Availability, willingness, ability, and sufficient cognitive awareness to comply with examination procedures and study visits
- • Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries
- • Ability to understand and respond to a questionnaire in English
- Exclusion Criteria:
- • Any conditions or circumstances, including those specified in the TECNIS Eyhance™ IOL Directions for Use, that, in the opinion of the investigator, may increase risk over benefit or result in an adverse event during the study.
- • Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)
- • Concurrent participation or participation within 60 days prior to preoperative visit in any other clinical trial
- • Desire for monovision correction
About Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc. is a leading global company dedicated to advancing the field of ophthalmic surgery through innovative technologies and solutions. As a subsidiary of Johnson & Johnson, it specializes in the development and commercialization of products for cataract and refractive surgery, focusing on improving patient outcomes and enhancing surgical precision. With a commitment to research and development, the company collaborates with healthcare professionals to deliver cutting-edge medical devices and instrumentation that address the evolving needs of eye care providers and their patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kingston, Pennsylvania, United States
Houston, Texas, United States
Sioux City, Iowa, United States
Sarasota, Florida, United States
Bakersfield, California, United States
San Antonio, Texas, United States
Saint Louis, Missouri, United States
Hurst, Texas, United States
Dallas, Texas, United States
Annapolis, Maryland, United States
San Antonio, Texas, United States
Houston, Texas, United States
Long Beach, California, United States
Cranberry Township, Pennsylvania, United States
San Antonio, Texas, United States
Patients applied
Trial Officials
Johnson & Johnson Surgical Vision Clinical Trials
Study Director
Johnson & Johnson Surgical Vision
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials